Literature DB >> 19720727

Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt.

Andreas Zeller1, M Verena Wenzl, Matteo Beretta, Heike Stessel, Michael Russwurm, Doris Koesling, Kurt Schmidt, Bernd Mayer.   

Abstract

Nitroxyl (HNO) may be formed endogenously by uncoupled nitric-oxide (NO) synthases, enzymatic reduction of NO or as product of vascular nitroglycerin bioactivation. The established HNO donor Angeli's salt (trioxodinitrate, AS) causes cGMP-dependent vasodilation through activation of soluble guanylate cyclase (sGC). We investigated the mechanisms underlying this effect using purified sGC and cultured endothelial cells. AS (up to 0.1 mM) had no significant effect on sGC activity in the absence of superoxide dismutase (SOD) or dithiothreitol (DTT). In the presence of SOD, AS caused biphasic sGC activation (apparent EC(50) approximately 10 nM, maximum at 1 microM) that was accompanied by the formation of NO. DTT (2 mM) inhibited the effects of <10 microM AS but led to sGC activation and NO release at 0.1 mM AS even without SOD. AS had no effect on ferric sGC, excluding activation of the oxidized enzyme by HNO. The NO scavenger carboxy-PTIO inhibited endothelial cGMP accumulation induced by AS in the presence but not in the absence of SOD (EC(50) approximately 50 nM and approximately 16 microM, respectively). Carboxy-PTIO (0.1 mM) inhibited the effect of <or=10 microM AS in the presence of SOD but caused NO release from 0.1 mM AS in the absence of SOD. These data indicate that AS activates sGC exclusively via NO, formed either via SOD-catalyzed oxidation of HNO or through a minor AS decomposition pathway that is unmasked in the presence of HNO scavenging thiols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720727     DOI: 10.1124/mol.109.059915

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

Review 1.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

2.  Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.

Authors:  Guangshuo Zhu; Dieter Groneberg; Gautam Sikka; Daijiro Hori; Mark J Ranek; Taishi Nakamura; Eiki Takimoto; Nazareno Paolocci; Dan E Berkowitz; Andreas Friebe; David A Kass
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

Review 3.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

4.  The nitroxyl donor, Angeli's salt, inhibits inflammatory hyperalgesia in rats.

Authors:  Ana C Zarpelon; Guilherme R Souza; Thiago M Cunha; Ieda R S Schivo; Mario Marchesi; Rubia Casagrande; Phileno Pinge-Filho; Fernando Q Cunha; Sergio H Ferreira; Katrina M Miranda; Waldiceu A Verri
Journal:  Neuropharmacology       Date:  2013-03-27       Impact factor: 5.250

Review 5.  Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

Review 6.  The chemical biology of HNO signaling.

Authors:  Christopher L Bianco; John P Toscano; Michael D Bartberger; Jon M Fukuto
Journal:  Arch Biochem Biophys       Date:  2016-08-20       Impact factor: 4.013

7.  Rapid and selective nitroxyl (HNO) trapping by phosphines: kinetics and new aqueous ligations for HNO detection and quantitation.

Authors:  Julie A Reisz; Charles N Zink; S Bruce King
Journal:  J Am Chem Soc       Date:  2011-07-11       Impact factor: 15.419

Review 8.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

9.  Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.

Authors:  Sonia Donzelli; Gerry Fischer; Bruce S King; Christin Niemann; Jenna F DuMond; Jörg Heeren; Hartwig Wieboldt; Stephan Baldus; Christian Gerloff; Thomas Eschenhagen; Lucie Carrier; Rainer H Böger; Michael Graham Espey
Journal:  J Pharmacol Exp Ther       Date:  2012-12-04       Impact factor: 4.030

10.  Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway.

Authors:  Larissa Staurengo-Ferrari; Ana C Zarpelon; Daniela T Longhi-Balbinot; Mario Marchesi; Thiago M Cunha; José C Alves-Filho; Fernando Q Cunha; Sergio H Ferreira; Rubia Casagrande; Katrina M Miranda; Waldiceu A Verri
Journal:  Pharmacol Rep       Date:  2014-04-22       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.